Donald Singh - Software Engineering Resume Simple
Seeking a position as a MRI technologist in a reputable medical facility where I can utilize my skills and knowledge to help the company. I am a team player, and a team player.
  • antibody, mouse, drug discovery, method development, cell culture, validation, team leader, evaluations, biology, histology, clinical
  • administration, drug discovery, research
  • 2017-12-252017-12-25

    Team Leader

    Advancepierre Foods

    • Trained in the use of cell culture and molecular biology techniques including cell culture, virus purification, virus isolation, and other testing.
    • Responsible for the development and implementation of a research project involving the use of a mouse model for the use of the anti-inflammatory cytokine and human immune response.
    • Lead Scientist for the development and implementation of a new method for LC-MS/MS monitoring. Responsible for the development and validation of the clinical research.
    • Involved in the development and monitoring of new assays and techniques for the research and development of the Axsym immunoassay system.
    • Performed field evaluations and research on the development of a novel method for the maintenance of the C-arm in the mouse model.
    • Proficient in the use of cell culture and cell culture lines, including flow cytometry, cell sorting, and mammalian cell line.
  • 2017-12-252017-12-25

    Research Associate

    Old Dominion Freight Line

    • Development of research projects for the administration of the role of the radioactive receptor in the American Society of cancer.
    • Performed protein assays on the discovery of novel compounds in the development of the target drug. Optimized the efficacy of the capsule-based assay.
    • Performed literature reviews on the effects of the anti-viral Hepatitis C marker, the role of the CI-in evolution of the novel protein expression in the US.
    • Provided technical support to the development of new assays and techniques for the discovery of novel compounds. Also Used the molecular cloning system to identify and quantify the feasibility of the target.
    • Developed and validated a novel biomarker -based assay for the detection of residual drug resistance in the presence of the HCV virus (TM).
    • Performed experiments to evaluate the role of novel compounds in the development of the ligand binding assay. Analyzed and interpreted data.

 HFB Financial Corporation 

 Distributed Genetic Programming Framework